|
|||||
|
|
Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis |
|
| Authors: | Moradzadeh Maliheh Aghaei Mehrdad Mehrbakhsh Zahra Arab-Bafrani Zahra Abdollahi Nafiseh |
| Affiliation: | 1.Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran ;2.Department of Biostatistics, Faculty of Health, Hamadan University of Medical Sciences, Hamadan, Iran ;3.Department of Biostaticstics, School of Health, Golestan University of Medical Sciences, Gorgan, Iran ;4.Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran ;5.Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran ;6.Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran ; |
| Abstract: | Clinical Rheumatology - The clinical benefits of rituximab in systemic sclerosis (SSc) are still contentious. The present meta-analysis aimed to systematically assess rituximab’s safety and... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |